September is Childhood Cancer Awareness Month, a time to recognize the children and families affected by childhood cancers, as well as emphasize the importance of research into these devastating conditions.
Childhood cancer remains the number one cause of death by disease for children in the United States. Each year, more than 15,000 children in the U.S. aged 0-19 are diagnosed, according to the American Childhood Cancer Organization.
Put another way, approximately 1 in 285 children in the U.S. will be diagnosed with cancer before their 20th birthday.
No child or family should have to suffer from the horrible impact of childhood cancer. America’s biopharmaceutical companies are committed to advancing innovative and therapeutically appropriate medicines to battle this terrible reality.